| 000 | 01439 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516074336.0 | ||
| 264 | 0 | _c20120914 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1433-2965 | ||
| 024 | 7 |
_a10.1007/s00198-011-1836-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYilmaz, M | |
| 245 | 0 | 0 |
_aNephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis. _h[electronic resource] |
| 260 |
_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _cJul 2012 |
||
| 300 |
_a2059-62 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlendronate _xadverse effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 700 | 1 | _aTaninmis, H | |
| 700 | 1 | _aKara, E | |
| 700 | 1 | _aOzagari, A | |
| 700 | 1 | _aUnsal, A | |
| 773 | 0 |
_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 23 _gno. 7 _gp. 2059-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00198-011-1836-2 _zAvailable from publisher's website |
| 999 |
_c21492625 _d21492625 |
||